Xarelto

Disclosure: Johnson and Johnson Product Liability Claims

Talcum Powder Litigation: J&J Logo

Johnson and Johnson product liability claims are described in detail in the company’s quarterly report filed with the SEC and released earlier this month. The company declines to put losses on its balance sheet “until a loss is determined to be probable and can be reasonably estimated.” According to Johnson and Johnson: The most significant…

Read More

Blood Thinners Associated with 3,000 Deaths in 2016

blood-thinners-death-risk

More than one million “adverse events” related to drugs were reported to the FDA in 2016. Among this overwhelming number, around 22,000 complaints concerned oral anticoagulants drugs like Xarelto, Eliquis, and other familiar brand names.  Even more concerning is the fact that this class of drug, more commonly known as blood thinners, were associated with…

Read More

Janssen Leans on Olympians and Athletes to Push Xarelto

xarelto side effects

The latest ad spot for Xarelto has all the hallmarks of a direct-to-consumer drug advertisement: cheery music, a story of redemption, and a mile-long list of side-effects rattled off as quickly as possible. This time, however, Xarelto’s manufacturer Bayer and its marketing team at Janssen have lured in an Olympian and an athlete to distract…

Read More

Xarelto Is the Worst Offender In a Study of Blood Thinners

Mayo Clinic building

A new study examining the relative effectiveness of modern blood thinners finds that Xarelto is the most likely to cause gastrointestinal (GI) bleeding. Researchers at the mayo Clinic conducted a large population-based study on three popular anticoagulant brands: Eliquis, Pradaxa, and Xarelto. Data from more than 50,000 patients was analyzed to determine rates of GI bleeding, which is…

Read More

Xarelto Receives Mixed Press as 2016 Comes to a Close

Janssen Pharma Office Netherlands

Most drugs are subject to varied press coverage over their lifetime. Blood-thinner Xarelto is no exception, as the latest research and legal challenges jockey for headline position as the year draws to a close. First, the good news… This week a new analysis of the drug’s impact on blood clots found cancer patients treated with…

Read More

Xarelto Lawsuits

judge gavel

Oral anticoagulant Rivaroxaban, better known as Xarelto, has been at the center of numerous lawsuits due to a serious and dangerous side effect of uncontrollable bleeding. Xarelto is a blood thinner manufactured by Bayer and marketed by Johnson & Johnson’s subsidiary Janssen Pharmaceuticals, prescribed to patients suffering from atrial fibrillation to help prevent blood clots. The…

Read More

Xarelto Commercial With Nealon and Vickers

Xeralto Logo

This is the original Xarelto commercial with Kevin Nealon and Brain Vickers, aired in 2015. While it lists several crucial side effects like bruising, nerve pain, and uncontrollable bleeding, the general air is that the drug provides liberation from the worries of blood clots and stroke. The convenience and effectiveness of Xarelto is certainly attractive,…

Read More